Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

NCT00452634 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER_GOV

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Irinotecan
DRUG: Cisplatin
DRUG: Simvastatin

Sponsor

National Cancer Center, Korea